Global Organ and Tissue Transplantation and Alternative Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 102

Published Date: 04 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Organ transplantation as a therapeutic strategy for patients with end-stage organ disease have been achieved due to greater insight into the immunobiology of graft rejection and better measures for surgical and medical management.

According to our (Global Info Research) latest study, the global Organ and Tissue Transplantation and Alternative market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Organ and Tissue Transplantation and Alternative market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Organ and Tissue Transplantation and Alternative market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ and Tissue Transplantation and Alternative market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ and Tissue Transplantation and Alternative market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ and Tissue Transplantation and Alternative market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Organ and Tissue Transplantation and Alternative
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Organ and Tissue Transplantation and Alternative market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Arthrex, Biomet, Bristol-Myers and Centacor, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Organ and Tissue Transplantation and Alternative market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Organ Transplantation
    Tissue Transplantation
    Cell Transplantation

Market segment by Application
    Hospital
    Clinic
    Laboratory

Major players covered
    Abbott
    Arthrex
    Biomet
    Bristol-Myers
    Centacor
    CryoLife, Inc.
    Dr. Franz Köhler Chemie GmbH
    Novartis
    Organ Transport Systems
    Organogenesis, Inc.
    XVIVO Perfusion AB

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Organ and Tissue Transplantation and Alternative product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Organ and Tissue Transplantation and Alternative, with price, sales, revenue and global market share of Organ and Tissue Transplantation and Alternative from 2018 to 2023.
Chapter 3, the Organ and Tissue Transplantation and Alternative competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Organ and Tissue Transplantation and Alternative breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Organ and Tissue Transplantation and Alternative market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Organ and Tissue Transplantation and Alternative.
Chapter 14 and 15, to describe Organ and Tissue Transplantation and Alternative sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Organ and Tissue Transplantation and Alternative
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Organ and Tissue Transplantation and Alternative Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Organ Transplantation
        1.3.3 Tissue Transplantation
        1.3.4 Cell Transplantation
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Organ and Tissue Transplantation and Alternative Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Laboratory
    1.5 Global Organ and Tissue Transplantation and Alternative Market Size & Forecast
        1.5.1 Global Organ and Tissue Transplantation and Alternative Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Organ and Tissue Transplantation and Alternative Sales Quantity (2018-2029)
        1.5.3 Global Organ and Tissue Transplantation and Alternative Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Abbott
        2.1.1 Abbott Details
        2.1.2 Abbott Major Business
        2.1.3 Abbott Organ and Tissue Transplantation and Alternative Product and Services
        2.1.4 Abbott Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Abbott Recent Developments/Updates
    2.2 Arthrex
        2.2.1 Arthrex Details
        2.2.2 Arthrex Major Business
        2.2.3 Arthrex Organ and Tissue Transplantation and Alternative Product and Services
        2.2.4 Arthrex Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Arthrex Recent Developments/Updates
    2.3 Biomet
        2.3.1 Biomet Details
        2.3.2 Biomet Major Business
        2.3.3 Biomet Organ and Tissue Transplantation and Alternative Product and Services
        2.3.4 Biomet Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Biomet Recent Developments/Updates
    2.4 Bristol-Myers
        2.4.1 Bristol-Myers Details
        2.4.2 Bristol-Myers Major Business
        2.4.3 Bristol-Myers Organ and Tissue Transplantation and Alternative Product and Services
        2.4.4 Bristol-Myers Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Bristol-Myers Recent Developments/Updates
    2.5 Centacor
        2.5.1 Centacor Details
        2.5.2 Centacor Major Business
        2.5.3 Centacor Organ and Tissue Transplantation and Alternative Product and Services
        2.5.4 Centacor Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Centacor Recent Developments/Updates
    2.6 CryoLife, Inc.
        2.6.1 CryoLife, Inc. Details
        2.6.2 CryoLife, Inc. Major Business
        2.6.3 CryoLife, Inc. Organ and Tissue Transplantation and Alternative Product and Services
        2.6.4 CryoLife, Inc. Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 CryoLife, Inc. Recent Developments/Updates
    2.7 Dr. Franz Köhler Chemie GmbH
        2.7.1 Dr. Franz Köhler Chemie GmbH Details
        2.7.2 Dr. Franz Köhler Chemie GmbH Major Business
        2.7.3 Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Product and Services
        2.7.4 Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Dr. Franz Köhler Chemie GmbH Recent Developments/Updates
    2.8 Novartis
        2.8.1 Novartis Details
        2.8.2 Novartis Major Business
        2.8.3 Novartis Organ and Tissue Transplantation and Alternative Product and Services
        2.8.4 Novartis Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Novartis Recent Developments/Updates
    2.9 Organ Transport Systems
        2.9.1 Organ Transport Systems Details
        2.9.2 Organ Transport Systems Major Business
        2.9.3 Organ Transport Systems Organ and Tissue Transplantation and Alternative Product and Services
        2.9.4 Organ Transport Systems Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Organ Transport Systems Recent Developments/Updates
    2.10 Organogenesis, Inc.
        2.10.1 Organogenesis, Inc. Details
        2.10.2 Organogenesis, Inc. Major Business
        2.10.3 Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Product and Services
        2.10.4 Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Organogenesis, Inc. Recent Developments/Updates
    2.11 XVIVO Perfusion AB
        2.11.1 XVIVO Perfusion AB Details
        2.11.2 XVIVO Perfusion AB Major Business
        2.11.3 XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Product and Services
        2.11.4 XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 XVIVO Perfusion AB Recent Developments/Updates

3 Competitive Environment: Organ and Tissue Transplantation and Alternative by Manufacturer
    3.1 Global Organ and Tissue Transplantation and Alternative Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Organ and Tissue Transplantation and Alternative Revenue by Manufacturer (2018-2023)
    3.3 Global Organ and Tissue Transplantation and Alternative Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Organ and Tissue Transplantation and Alternative by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Organ and Tissue Transplantation and Alternative Manufacturer Market Share in 2022
        3.4.2 Top 6 Organ and Tissue Transplantation and Alternative Manufacturer Market Share in 2022
    3.5 Organ and Tissue Transplantation and Alternative Market: Overall Company Footprint Analysis
        3.5.1 Organ and Tissue Transplantation and Alternative Market: Region Footprint
        3.5.2 Organ and Tissue Transplantation and Alternative Market: Company Product Type Footprint
        3.5.3 Organ and Tissue Transplantation and Alternative Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Organ and Tissue Transplantation and Alternative Market Size by Region
        4.1.1 Global Organ and Tissue Transplantation and Alternative Sales Quantity by Region (2018-2029)
        4.1.2 Global Organ and Tissue Transplantation and Alternative Consumption Value by Region (2018-2029)
        4.1.3 Global Organ and Tissue Transplantation and Alternative Average Price by Region (2018-2029)
    4.2 North America Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029)
    4.3 Europe Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029)
    4.4 Asia-Pacific Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029)
    4.5 South America Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029)
    4.6 Middle East and Africa Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2029)
    5.2 Global Organ and Tissue Transplantation and Alternative Consumption Value by Type (2018-2029)
    5.3 Global Organ and Tissue Transplantation and Alternative Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2029)
    6.2 Global Organ and Tissue Transplantation and Alternative Consumption Value by Application (2018-2029)
    6.3 Global Organ and Tissue Transplantation and Alternative Average Price by Application (2018-2029)

7 North America
    7.1 North America Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2029)
    7.2 North America Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2029)
    7.3 North America Organ and Tissue Transplantation and Alternative Market Size by Country
        7.3.1 North America Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2018-2029)
        7.3.2 North America Organ and Tissue Transplantation and Alternative Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2029)
    8.2 Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2029)
    8.3 Europe Organ and Tissue Transplantation and Alternative Market Size by Country
        8.3.1 Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2018-2029)
        8.3.2 Europe Organ and Tissue Transplantation and Alternative Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Organ and Tissue Transplantation and Alternative Market Size by Region
        9.3.1 Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Organ and Tissue Transplantation and Alternative Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2029)
    10.2 South America Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2029)
    10.3 South America Organ and Tissue Transplantation and Alternative Market Size by Country
        10.3.1 South America Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2018-2029)
        10.3.2 South America Organ and Tissue Transplantation and Alternative Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Organ and Tissue Transplantation and Alternative Market Size by Country
        11.3.1 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Organ and Tissue Transplantation and Alternative Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Organ and Tissue Transplantation and Alternative Market Drivers
    12.2 Organ and Tissue Transplantation and Alternative Market Restraints
    12.3 Organ and Tissue Transplantation and Alternative Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Organ and Tissue Transplantation and Alternative and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Organ and Tissue Transplantation and Alternative
    13.3 Organ and Tissue Transplantation and Alternative Production Process
    13.4 Organ and Tissue Transplantation and Alternative Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Organ and Tissue Transplantation and Alternative Typical Distributors
    14.3 Organ and Tissue Transplantation and Alternative Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Organ and Tissue Transplantation and Alternative Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Organ and Tissue Transplantation and Alternative Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Abbott Basic Information, Manufacturing Base and Competitors
    Table 4. Abbott Major Business
    Table 5. Abbott Organ and Tissue Transplantation and Alternative Product and Services
    Table 6. Abbott Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Abbott Recent Developments/Updates
    Table 8. Arthrex Basic Information, Manufacturing Base and Competitors
    Table 9. Arthrex Major Business
    Table 10. Arthrex Organ and Tissue Transplantation and Alternative Product and Services
    Table 11. Arthrex Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Arthrex Recent Developments/Updates
    Table 13. Biomet Basic Information, Manufacturing Base and Competitors
    Table 14. Biomet Major Business
    Table 15. Biomet Organ and Tissue Transplantation and Alternative Product and Services
    Table 16. Biomet Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Biomet Recent Developments/Updates
    Table 18. Bristol-Myers Basic Information, Manufacturing Base and Competitors
    Table 19. Bristol-Myers Major Business
    Table 20. Bristol-Myers Organ and Tissue Transplantation and Alternative Product and Services
    Table 21. Bristol-Myers Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Bristol-Myers Recent Developments/Updates
    Table 23. Centacor Basic Information, Manufacturing Base and Competitors
    Table 24. Centacor Major Business
    Table 25. Centacor Organ and Tissue Transplantation and Alternative Product and Services
    Table 26. Centacor Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Centacor Recent Developments/Updates
    Table 28. CryoLife, Inc. Basic Information, Manufacturing Base and Competitors
    Table 29. CryoLife, Inc. Major Business
    Table 30. CryoLife, Inc. Organ and Tissue Transplantation and Alternative Product and Services
    Table 31. CryoLife, Inc. Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. CryoLife, Inc. Recent Developments/Updates
    Table 33. Dr. Franz Köhler Chemie GmbH Basic Information, Manufacturing Base and Competitors
    Table 34. Dr. Franz Köhler Chemie GmbH Major Business
    Table 35. Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Product and Services
    Table 36. Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Dr. Franz Köhler Chemie GmbH Recent Developments/Updates
    Table 38. Novartis Basic Information, Manufacturing Base and Competitors
    Table 39. Novartis Major Business
    Table 40. Novartis Organ and Tissue Transplantation and Alternative Product and Services
    Table 41. Novartis Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Novartis Recent Developments/Updates
    Table 43. Organ Transport Systems Basic Information, Manufacturing Base and Competitors
    Table 44. Organ Transport Systems Major Business
    Table 45. Organ Transport Systems Organ and Tissue Transplantation and Alternative Product and Services
    Table 46. Organ Transport Systems Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Organ Transport Systems Recent Developments/Updates
    Table 48. Organogenesis, Inc. Basic Information, Manufacturing Base and Competitors
    Table 49. Organogenesis, Inc. Major Business
    Table 50. Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Product and Services
    Table 51. Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Organogenesis, Inc. Recent Developments/Updates
    Table 53. XVIVO Perfusion AB Basic Information, Manufacturing Base and Competitors
    Table 54. XVIVO Perfusion AB Major Business
    Table 55. XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Product and Services
    Table 56. XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. XVIVO Perfusion AB Recent Developments/Updates
    Table 58. Global Organ and Tissue Transplantation and Alternative Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 59. Global Organ and Tissue Transplantation and Alternative Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 60. Global Organ and Tissue Transplantation and Alternative Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 61. Market Position of Manufacturers in Organ and Tissue Transplantation and Alternative, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 62. Head Office and Organ and Tissue Transplantation and Alternative Production Site of Key Manufacturer
    Table 63. Organ and Tissue Transplantation and Alternative Market: Company Product Type Footprint
    Table 64. Organ and Tissue Transplantation and Alternative Market: Company Product Application Footprint
    Table 65. Organ and Tissue Transplantation and Alternative New Market Entrants and Barriers to Market Entry
    Table 66. Organ and Tissue Transplantation and Alternative Mergers, Acquisition, Agreements, and Collaborations
    Table 67. Global Organ and Tissue Transplantation and Alternative Sales Quantity by Region (2018-2023) & (K Units)
    Table 68. Global Organ and Tissue Transplantation and Alternative Sales Quantity by Region (2024-2029) & (K Units)
    Table 69. Global Organ and Tissue Transplantation and Alternative Consumption Value by Region (2018-2023) & (USD Million)
    Table 70. Global Organ and Tissue Transplantation and Alternative Consumption Value by Region (2024-2029) & (USD Million)
    Table 71. Global Organ and Tissue Transplantation and Alternative Average Price by Region (2018-2023) & (US$/Unit)
    Table 72. Global Organ and Tissue Transplantation and Alternative Average Price by Region (2024-2029) & (US$/Unit)
    Table 73. Global Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2023) & (K Units)
    Table 74. Global Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2024-2029) & (K Units)
    Table 75. Global Organ and Tissue Transplantation and Alternative Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Global Organ and Tissue Transplantation and Alternative Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Global Organ and Tissue Transplantation and Alternative Average Price by Type (2018-2023) & (US$/Unit)
    Table 78. Global Organ and Tissue Transplantation and Alternative Average Price by Type (2024-2029) & (US$/Unit)
    Table 79. Global Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2023) & (K Units)
    Table 80. Global Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2024-2029) & (K Units)
    Table 81. Global Organ and Tissue Transplantation and Alternative Consumption Value by Application (2018-2023) & (USD Million)
    Table 82. Global Organ and Tissue Transplantation and Alternative Consumption Value by Application (2024-2029) & (USD Million)
    Table 83. Global Organ and Tissue Transplantation and Alternative Average Price by Application (2018-2023) & (US$/Unit)
    Table 84. Global Organ and Tissue Transplantation and Alternative Average Price by Application (2024-2029) & (US$/Unit)
    Table 85. North America Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2023) & (K Units)
    Table 86. North America Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2024-2029) & (K Units)
    Table 87. North America Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2023) & (K Units)
    Table 88. North America Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2024-2029) & (K Units)
    Table 89. North America Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2018-2023) & (K Units)
    Table 90. North America Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2024-2029) & (K Units)
    Table 91. North America Organ and Tissue Transplantation and Alternative Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. North America Organ and Tissue Transplantation and Alternative Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2023) & (K Units)
    Table 94. Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2024-2029) & (K Units)
    Table 95. Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2023) & (K Units)
    Table 96. Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2024-2029) & (K Units)
    Table 97. Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2018-2023) & (K Units)
    Table 98. Europe Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2024-2029) & (K Units)
    Table 99. Europe Organ and Tissue Transplantation and Alternative Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Organ and Tissue Transplantation and Alternative Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2023) & (K Units)
    Table 102. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2024-2029) & (K Units)
    Table 103. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2023) & (K Units)
    Table 104. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2024-2029) & (K Units)
    Table 105. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Region (2018-2023) & (K Units)
    Table 106. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity by Region (2024-2029) & (K Units)
    Table 107. Asia-Pacific Organ and Tissue Transplantation and Alternative Consumption Value by Region (2018-2023) & (USD Million)
    Table 108. Asia-Pacific Organ and Tissue Transplantation and Alternative Consumption Value by Region (2024-2029) & (USD Million)
    Table 109. South America Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2023) & (K Units)
    Table 110. South America Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2024-2029) & (K Units)
    Table 111. South America Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2023) & (K Units)
    Table 112. South America Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2024-2029) & (K Units)
    Table 113. South America Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2018-2023) & (K Units)
    Table 114. South America Organ and Tissue Transplantation and Alternative Sales Quantity by Country (2024-2029) & (K Units)
    Table 115. South America Organ and Tissue Transplantation and Alternative Consumption Value by Country (2018-2023) & (USD Million)
    Table 116. South America Organ and Tissue Transplantation and Alternative Consumption Value by Country (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2018-2023) & (K Units)
    Table 118. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Type (2024-2029) & (K Units)
    Table 119. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2018-2023) & (K Units)
    Table 120. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Application (2024-2029) & (K Units)
    Table 121. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Region (2018-2023) & (K Units)
    Table 122. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity by Region (2024-2029) & (K Units)
    Table 123. Middle East & Africa Organ and Tissue Transplantation and Alternative Consumption Value by Region (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Organ and Tissue Transplantation and Alternative Consumption Value by Region (2024-2029) & (USD Million)
    Table 125. Organ and Tissue Transplantation and Alternative Raw Material
    Table 126. Key Manufacturers of Organ and Tissue Transplantation and Alternative Raw Materials
    Table 127. Organ and Tissue Transplantation and Alternative Typical Distributors
    Table 128. Organ and Tissue Transplantation and Alternative Typical Customers
List of Figures
    Figure 1. Organ and Tissue Transplantation and Alternative Picture
    Figure 2. Global Organ and Tissue Transplantation and Alternative Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Type in 2022
    Figure 4. Organ Transplantation Examples
    Figure 5. Tissue Transplantation Examples
    Figure 6. Cell Transplantation Examples
    Figure 7. Global Organ and Tissue Transplantation and Alternative Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Application in 2022
    Figure 9. Hospital Examples
    Figure 10. Clinic Examples
    Figure 11. Laboratory Examples
    Figure 12. Global Organ and Tissue Transplantation and Alternative Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Organ and Tissue Transplantation and Alternative Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Organ and Tissue Transplantation and Alternative Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Organ and Tissue Transplantation and Alternative Average Price (2018-2029) & (US$/Unit)
    Figure 16. Global Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Organ and Tissue Transplantation and Alternative by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Organ and Tissue Transplantation and Alternative Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Organ and Tissue Transplantation and Alternative Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Organ and Tissue Transplantation and Alternative Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Organ and Tissue Transplantation and Alternative Average Price by Type (2018-2029) & (US$/Unit)
    Figure 31. Global Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Organ and Tissue Transplantation and Alternative Average Price by Application (2018-2029) & (US$/Unit)
    Figure 34. North America Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Organ and Tissue Transplantation and Alternative Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Organ and Tissue Transplantation and Alternative Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Organ and Tissue Transplantation and Alternative Market Drivers
    Figure 75. Organ and Tissue Transplantation and Alternative Market Restraints
    Figure 76. Organ and Tissue Transplantation and Alternative Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Organ and Tissue Transplantation and Alternative in 2022
    Figure 79. Manufacturing Process Analysis of Organ and Tissue Transplantation and Alternative
    Figure 80. Organ and Tissue Transplantation and Alternative Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott
Arthrex
Biomet
Bristol-Myers
Centacor
CryoLife, Inc.
Dr. Franz Köhler Chemie GmbH
Novartis
Organ Transport Systems
Organogenesis, Inc.
XVIVO Perfusion AB

Related Reports

Global Organ and Tissue Transplantation and Alternative Supply, Demand and Key Producers, 2023-2029

Global Organ and Tissue Transplantation and Alternative Supply, Demand and Key Producers, 2023-2029

date 13 Feb 2023

date Medical Devices & Consumables

The global Organ and Tissue Transplantation and Alternative market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Organ and Tissue Transplantation and Alternative Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Organ and Tissue Transplantation and Alternative Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 15 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Organ and Tissue Transplantation and Alternative market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Organ and Tissue Transplantation and Alternative

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>